Upstream Bio (UPB) Cost of Revenue: 2024-2025
Historic Cost of Revenue for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $2.5 million.
- Upstream Bio's Cost of Revenue rose 16.66% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.4 million, marking a year-over-year change of. This contributed to the annual value of $6.6 million for FY2024, which is 95.08% up from last year.
- Per Upstream Bio's latest filing, its Cost of Revenue stood at $2.5 million for Q3 2025, which was down 74.58% from $10.0 million recorded in Q2 2025.
- In the past 5 years, Upstream Bio's Cost of Revenue ranged from a high of $10.0 million in Q2 2025 and a low of $351,000 during Q1 2024.
- For the 2-year period, Upstream Bio's Cost of Revenue averaged around $3.1 million, with its median value being $2.2 million (2024).
- Data for Upstream Bio's Cost of Revenue shows a peak YoY spiked of 606.21% (in 2025) over the last 5 years.
- Upstream Bio's Cost of Revenue (Quarterly) stood at $2.8 million in 2024, then increased by 16.66% to $2.5 million in 2025.
- Its Cost of Revenue was $2.5 million in Q3 2025, compared to $10.0 million in Q2 2025 and $2.1 million in Q1 2025.